These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7669184)

  • 21. Enzymatic resolution for the preparation of enantiomerically enriched D-beta-heterocyclic alanine derivatives using Escherichia coli aromatic L-amino acid transaminase.
    Cho BK; Park HY; Seo JH; Kinnera K; Lee BS; Kim BG
    Biotechnol Bioeng; 2004 Nov; 88(4):512-9. PubMed ID: 15459908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins.
    Hubschwerlen C; Angehrn P; Gubernator K; Page MG; Specklin JL
    J Med Chem; 1998 Oct; 41(21):3972-5. PubMed ID: 9767634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inverse acyl phosph(on)ates: substrates or inhibitors of beta-lactam-recognizing enzymes?
    Morrison MJ; Li N; Pratt RF
    Bioorg Chem; 2001 Oct; 29(5):271-81. PubMed ID: 16256697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transpeptidation reactions of a specific substrate catalyzed by the Streptomyces R61 DD-peptidase: the structural basis of acyl acceptor specificity.
    Kumar I; Pratt RF
    Biochemistry; 2005 Aug; 44(30):9961-70. PubMed ID: 16042373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assays for beta-lactamase activity and inhibition.
    Viswanatha T; Marrone L; Goodfellow V; Dmitrienko GI
    Methods Mol Med; 2008; 142():239-60. PubMed ID: 18437319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reactions of derivatives of beta-lactam antibiotics with non-antibacterial biological activity].
    Gunda T
    Acta Pharm Hung; 2002; 72(4):223-30. PubMed ID: 12812042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biochemical evaluation of some novel N-acyl phosphono- and phosphinoalanine derivatives as potential inhibitors of the D-glutamic acid-adding enzyme.
    Gobec S; Urleb U; Auger G; Blanot D
    Pharmazie; 2001 Apr; 56(4):295-7. PubMed ID: 11338666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and SAR of novel oxazolidinones: discovery of ranbezolid.
    Das B; Rudra S; Yadav A; Ray A; Rao AV; Srinivas AS; Soni A; Saini S; Shukla S; Pandya M; Bhateja P; Malhotra S; Mathur T; Arora SK; Rattan A; Mehta A
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4261-7. PubMed ID: 16054358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel tricyclic inhibitors of IkappaB kinase.
    Kempson J; Spergel SH; Guo J; Quesnelle C; Gill P; Belanger D; Dyckman AJ; Li T; Watterson SH; Langevine CM; Das J; Moquin RV; Furch JA; Marinier A; Dodier M; Martel A; Nirschl D; Van Kirk K; Burke JR; Pattoli MA; Gillooly K; McIntyre KW; Chen L; Yang Z; Marathe PH; Wang-Iverson D; Dodd JH; McKinnon M; Barrish JC; Pitts WJ
    J Med Chem; 2009 Apr; 52(7):1994-2005. PubMed ID: 19267461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of beta-lactamases by 6,6-bis(hydroxylmethyl)penicillanate.
    Nagase T; Golemi D; Ishiwata A; Mobashery S
    Bioorg Chem; 2001 Jun; 29(3):140-5. PubMed ID: 11437389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-secondary and solvent deuterium kinetic isotope effects on catalysis by the Streptomyces R61 DD-peptidase: comparisons with a structurally similar class C beta-lactamase.
    Adediran SA; Pratt RF
    Biochemistry; 1999 Feb; 38(5):1469-77. PubMed ID: 9931012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanomolar inhibitors of AmpC beta-lactamase.
    Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
    J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and structure-activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases.
    Frazier K; Jazan E; McBride CM; Pecchi S; Renhowe PA; Shafer CM; Taylor C; Bussiere D; He MM; Jansen JM; Lapointe G; Ma S; Vora J; Wiesmann M
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2247-51. PubMed ID: 16446087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence.
    Totir MA; Cha J; Ishiwata A; Wang B; Sheri A; Anderson VE; Buynak J; Mobashery S; Carey PR
    Biochemistry; 2008 Apr; 47(13):4094-101. PubMed ID: 18324783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 3-Substituted-clavams: Antifungal Properties, DD-Peptidase and beta-Lactamase Inhibition.
    Cierpucha M; Panfil I; Danh TT; Chmielewski M; Kurzatkowski W; Rajnisz A; Solecka J
    J Antibiot (Tokyo); 2007 Oct; 60(10):622-32. PubMed ID: 17965478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor imidazotetrazinones: prodrugs targeted to the major groove of DNA.
    Stevens MF
    Farmaco; 1991 Jan; 46(1 Suppl):147-59. PubMed ID: 1854402
    [No Abstract]   [Full Text] [Related]  

  • 38. Compounds related to clomethiazole. 3. 4,5-dialkyl-substituted thiazoles, oxazoles and imidazoles.
    Lindberg UH; Bexell G; Pedersen J; Ross S
    Acta Pharm Suec; 1970 Sep; 7(4):423-34. PubMed ID: 5480082
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel Benzo[d]imidazole-based Heterocycles as Broad Spectrum Anti-viral Agents: Design, Synthesis and Exploration of Molecular Basis of Action.
    Eldebss TM; Farag AM; Abdulla MM; Arafa RK
    Mini Rev Med Chem; 2016; 16(1):67-83. PubMed ID: 26527409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Convenient synthesis of 5-trifluoroacetylated imidazoles by ring transformation of mesoionic 1,3-oxazolium-5-olates.
    Kawase M; Saito S
    Chem Pharm Bull (Tokyo); 2000 Mar; 48(3):410-4. PubMed ID: 10726867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.